Title (en)

CRYSTALLINE (R)-2-(4-AMIDINOPHENYLAMINOMETHYL)-1-METHYL-5-(1-(CARBOXYMETHYLAMINO)-1(PYRROLIDINOCARBONYL)-ETHYL)-BENZIMIDAZOLE, AND THE USE THEREOF AS ANTITHROMBOTIC AGENTS

Title (de)

KRISTALLINES (R) 2-(4-AMIDINOPHENYLAMINOMETHYL)-1-METHYL-5-¬1-(CARBOXYMETHYLAMINO)-1 (PYRROLIDINOCARBONYL)-ETHYL -BENZIMIDAZOL SOWIE DESSEN VERWENDUNG ALS ANTITHROMBOSEMITTEL

Title (fr)

(R)-2-(4-AMIDINOPHENYLAMINOMETHYL)-1-METHYL-5-(1-(CARBOXYMETHYLAMINO)-1(PYRROLIDINOCARBONYL)-ETHYL)-BENZIMIDAZOL CRISTALLIN, ET UTILISATION DE LADITE SUBSTANCE EN TANT QUE MEDICAMENT ANTITHROMBOTIQUE

Publication

EP 1529035 A1 20050511 (DE)

Application

EP 03735629 A 20030616

Priority

• DE 10227666 A 20020620
• EP 0306317 W 20030616

Abstract (en)

[origin: CA2485545A1] The invention relates to the crystalline forms of compounds (R)-2-(4- amidinophenylaminomethyl)-1-methyl-5-(1-(carboxymethylamino)-1- (pyrrolidinocarbonyl)-ethyl)-benzimidazole and monohydrochloride thereof, to methods for the production thereof, and to their use as medicaments having a n antithrombotic action.

IPC 1-7

C07D 235/14; A61K 31/4184; A61P 7/02

IPC 8 full level

A61P 7/02 (2006.01); C07D 235/14 (2006.01); C07D 235/10 (2006.01)

CPC (source: EP)

A61P 7/02 (2017.12); A61P 9/00 (2017.12); A61P 9/10 (2017.12); A61P 11/00 (2017.12); C07D 235/14 (2013.01)

Citation (search report)

See references of WO 2004000818A1

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

DOCDB simple family (publication)

DE 10227666 A1 20040108; AR 040445 A1 20050406; AU 2003237945 A1 20040106; CA 2485545 A1 20031231; EP 1529035 A1 20050511; JP 2006508037 A 20060309; TW 200413329 A 20040801; UY 27856 A1 20031231; WO 2004000818 A1 20031231

DOCDB simple family (application)

DE 10227666 A 20020620; AR P030102210 A 20030620; AU 2003237945 A 20030616; CA 2485545 A 20030616; EP 0306317 W 20030616; EP 03735629 A 20030616; JP 2004514726 A 20030616; TW 92116667 A 20030619; UY 27856 A 20030618